Pulmonary hypertension is a common consequence of interstitial lung disease (PH-ILD), with the highest rate seen among ...
Strong positive interim data from an earlier Phase 3 trial has led to early cessation of Merck’s pulmonary arterial ...
At age 3, Chris jumped off his bed pretending to be a wrestler, and broke his calf bone. He got a green cast, and Dana drew ...
The abnormal accumulation of extravascular fluid, pulmonary edema settles in the lung interstitium and alveoli. There, it ...
Pulmonary arterial hypertension (PAH) can be a challenging complication to manage during pregnancy; women with PAH who are ...
CT scan-assessed high right ventricle-left ventricle ratio of the heart predicts major adverse cardiovascular events in PH ...
The leading Pulmonary Arterial Hypertension Companies such as Merck Sharp & Dohme, Acceleron Pharma, Liquidia Technologies, ...
A new program in the Central Valley is now offering much-needed treatments for patients suffering from an advanced form of lung disease called pulmonary ...
Highlight box Key findings • The bibliometric analysis summarized the major areas and promising research directions on chronic thromboembolic pulmonary hypertension (CTEPH) over the past two decades.
The investigators searched the American version of YouTube for videos in English, from 2004 to July 2024, concerning PR on non-COPD conditions (such as interstitial lung disease, pulmonary arterial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback